Most people with migraine-- about 70%-75% -- get migraine without aura. That usually comes with the things most associated with the disorder: head pain, nausea, and sensitivity to light and sound.

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...

Phantom smells (phantosmia) are a rare type of migraine aura. Aura often causes problems with vision and happens before the headache phase of a migraine attack. However, aura can also cause a person ...

A migraine episode may have up to four distinct stages or phases, each of varying duration: prodrome, aura, headache, and postdrome. However, not everyone experiences all four stages each time.

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 hours, and reduces the need for rescue medication.

A history of migraine, with or without aura, was a significant risk factor for open-angle glaucoma onset among a cohort of ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

Women taking the beta blocker propranolol to ward off migraines have a lower risk of strokes caused by blood clots, according ...

Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment ...